Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT? Registry.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT? Registry.
Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT? Registry. Am J Gastroenterol. 2014 Feb; 109(2):212-23.
View in:
PubMed
subject areas
Adult
Age Distribution
Analysis of Variance
Antibodies, Monoclonal
Cell Transformation, Neoplastic
Cohort Studies
Colorectal Neoplasms
Confidence Intervals
Crohn Disease
Female
Gastrointestinal Agents
Humans
Immunosuppressive Agents
Incidence
Infliximab
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Prognosis
Proportional Hazards Models
Prospective Studies
Registries
Risk Assessment
Sex Distribution
Smoking
Survival Rate
Tumor Necrosis Factor-alpha
authors with profiles
Russell D. Cohen